Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-28 · accession 0001127602-25-007530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-03 | 2025-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | M - OptEx | — | +137.9K | 75.5K | New | — |
| D | 2025-03-03 | 2025-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | F - Tax | $0.67 | -65.3K | 120.3K | -35% | -$43.8K |
| DM | 2025-03-03 | 2025-02-28 | LXRX | Granowitz Craig B | SVP, Chief Medical Off | M - OptEx | — | -137.9K | 148.5K | -48% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | M | A | 35,790 | — | 111,333 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Common | Common Stock | 2025-02-28 | M | A | 74,227 | — | 185,560 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2025-02-28 | F | D | 65,308 | $0.67 | 120,252 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-28 | M | A | 27,917 | — | 75,543 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 5 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 35,790 | — | 35,790 | D | — · — to — | 35,790 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 27,917 | — | 0 | D | — · — to — | 27,917 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 7 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 74,227 | — | 148,453 | D | — · — to — | 74,227 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |